Inhibition of Spinal Prostaglandin Synthesis Early after L5/L6 Nerve Ligation Prevents the Development of Prostaglandin-dependent and Prostaglandin-independent Allodynia in the Rat

Anesthesiology

Volumn 99, Issue 5, 2003, Pages 1180-1188

  Hefferan, Michael P ^a   O'Rielly, Darren D ^a   Loomis, Christopher W ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CYCLOOXYGENASE 1; GLUTAMIC ACID; IBUPROFEN; PROSTAGLANDIN; PROSTAGLANDIN E2;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CEREBROSPINAL FLUID; CONTROLLED STUDY; MALE; NERVE LIGATION; NEUROPATHIC PAIN; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN THRESHOLD; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DINOPROSTONE; GLUTAMIC ACID; IBUPROFEN; INJECTIONS, SPINAL; LIGATION; MALE; MICRODIALYSIS; PAIN; PAIN MEASUREMENT; PHYSICAL STIMULATION; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDINS; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SPINAL NERVES;

EID: 0242363752     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200311000-00027     Document Type: Article

References (59)

1. Malmberg AB, Yaksh TL: Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 1992; 257:1276-9
2. Yaksh TL, Malmberg AB: Spinal actions of NSAIDs in blocking spinally mediated hyperalgesia: The role of cyclooxygenase products. Agents Actions Suppl 1993; 41:89-100
3. McCormack K: Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain 1994; 59:9-43
4. McCormack K: The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects. Drugs 1994; 47:28-47
5. Southall MD, Michael RL, Vasko MR: Intrathecal NSAIDS attenuate inflammation-induced neuropeptide release from rat spinal cord slices. Pain 1998; 78:39-48
6. Matsumura K, Watanabe Y, Onoe H, Watanabe Y: Prostacyclin receptor in the brain and central terminals of the primary sensory neurons: An autoradiographic study using a stable prostacyclin analogue [3H]iloprost. Neuroscience 1995; 65:493-503
7. Goppelt-Struebe M, Beiche F: Cyclooxygenase-2 in the spinal cord: localization and regulation after a peripheral inflammatory stimulus. Adv Exp Med Biol 1997; 433:209-12
8. Willingale HL, Gardiner NJ, McLymont N, Giblett S, Grubb BD: Prostanoids synthesized by cyclo-oxygenase isoforms in the rat spinal cord and their contribution to the development of neuronal hyperexcitability. Br J Pharmacol 1997; 122:1593-604
9. Vane JR, Bakhle YS, Botting RM: Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998; 38:97-120
10. 2 and amino acids evoked by paw formalin injection: A microdialysis study in unanaesthetized rats. J Neurosci 1995; 15:2768-76
11. Millan MJ: The induction of pain: An integrative review. Prog Neurobiol 1999; 57:1-164
12. Merskey H: Classification of chronic pain, part II. Pain Suppl 1986; 3:S215-21
13. Baba H, Kohno T, Moore KA, Woolf CJ: Direct activation of rat spinal dorsal horn neurons by prostaglandin E2. J Neurosci 2001; 21:1750-6
14. Ferreira SH, Lorenzetti BB: Intrathecal administration of prostaglandin E2 causes sensitization of the primary afferent neuron via spinal release of glutamate. Inflamm Res 1996; 45:499-502
15. Hingtgen CM, Waite KJ, Vasko MR: Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3′, 5′-cyclic monophosphate transduction cascade. J Neurosci 1995; 15:5411-9
16. Ahmadi S, Lippross S, Neuhuber WL, Zeilhofer HU: PGE(2) selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons. Nat Neuroscience 2002; 5:34-40
17. Uda R, Horiguchi S, Ito S, Hyodo M, Hayaishi O: Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice. Brain Res 1990; 510:26-32
18. Minami T, Nishihara I, Sakamoto K, Ito S, Hyodo M, Hayaishi O: Blockade by ONO-NT-012, a unique prostanoid analogue, of prostaglandin E2-induced allodynia in conscious mice. Br J Pharmacol 1995; 115:73-6
19. Minami T, Uda R, Horiguchi S, Ito S, Hyodo M, Hayaishi O: Allodynia evoked by intrathecal administration of prostaglandin E2 to conscious mice. Pain 1994; 57:217-23
20. Yaksh T: Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: Effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 1989; 37:111-23
21. Milne B, Hall SR, Sullivan ME, Loomis C: The release of spinal prostaglandin E2 and the effect of nitric oxide synthetase inhibition during strychnine-induced allodynia. Anesth Analg 2001; 93:728-33
22. Hall SR, Milne B, Loomis C: Spinal action of ketorolac, S(+)- and R(-)-ibuprofen on non-noxious activation of the catechol oxidation in the rat locus coeruleus: Evidence for a central role of prostaglandins in the strychnine model of allodynia. ANESTHESIOLOGY 1999; 90:165-73
23. Zhang Z, Hefferan MP, Loomis CW: Topical bicuculline to the rat spinal cord induces highly localized allodynia that is mediated by spinal prostaglandins. Pain 2001; 92:351-61
24. Kim SH, Chung JM: An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992; 50:355-63
25. Zhao Z, Chen SR, Eisenach JC, Busija DW, Pan HL: Spinal cyclooxygenase-2 is involved in development of allodynia after nerve injury in rats. Neuroscience 2000; 97:743-8
26. Hefferan MP, Carter P, Haley M, Loomis CW: Spinal nerve injury activates prostaglandin synthesis in the spinal cord that contributes to early maintenance of tactile allodynia. Pain 2003; 101:139-47
27. Lee YW, Yaksh TL: Analysis of drug interaction between intrathecal clonidine and MK-801 in peripheral neuropathic pain rat model. ANESTHESIOLOGY 1995; 82:741-8
28. Khandwala H, Hodge E, Loomis C: Comparable dose-dependent inhibition of AP-7 sensitive strychnine-induced allodynia and paw pinch-induced nociception by mexiletine in the rat. Pain 1997; 72:299-308
29. Leung A, Wallace M, Ridgeway B, Yaksh T: Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Pain 2001; 91:177-87
30. Bennett AD, Everhart AW, Hulsebosch CE: Intrathecal administration of an NMDA or a non-NMDA receptor antagonist reduces mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury. Brain Res 2000; 859:72-82
31. Hao JX, Xu XJ: Treatment of a chronic allodynia-like response in spinally injured rats: Effects of systemically administered excitatory amino acid receptor antagonists. Pain 1996; 66:279-85
32. Minami T, Matsumura S, Okuda-Ashitaka E, Shimamoto K, Sakimura K, Mishina M, Mori H, Ito S: Characterization of the glutamatergic system for induction and maintenance of allodynia. Brain Res 2001; 895:178-85
33. Dirig DM, Yaksh TL: In vitro prostanoid release from spinal cord following peripheral inflammation: Effects of substance P, NMDA and capsaicin. Br J Pharmacol 1999; 126:1333-40
34. Urban L, Thompson SW, Dray A: Modulation of spinal excitability: Cooperation between neurokinin and excitatory amino acid neurotransmitters. Trends Neurosci 1994; 17:432-8
35. Marsala M, Malmberg AB, Yaksh TL: The spinal loop dialysis catheter: Characterization of use in the unanesthetized rat. J Neurosci Methods 1995; 62:43-53
36. Sherman SE, Loomis CW: Morphine insensitive allodynia is produced by intrathecal strychnine in the lightly anesthetized rat. Pain 1994; 56:17-29
37. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53: 55-63
38. Nicholls DG, Sihra TS, Sanchez-Prieto J: Calcium-dependent and -independent release of glutamate from synaptosomes monitored by continuous fluorometry. J Neurochem 1987; 49:50-7
39. Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzini BL, Pozzan T, Volterra A: Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 1998; 391:281-5
40. Vesce S, Bezzi P, Rossi D, Meldolesi J, Volterra A: HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid. FEBS Lett 1997; 411:107-9
41. Tallarida RJ, Murray RB: Manual of Pharmacologic Calculations with Computer Programs, 2nd edition. New York, Springer-Verlag, 1987, pp 10-30
42. Yaksh TL, Hua XY, Kalcheva I, Nozaki-Taguchi N, Marsala M: The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc Natl Acad Sci U S A 1999; 96:7680-6
43. Yaksh, TL: Spinal systems and pain processing: Development of novel analgesic drugs with mechanistically defined models. Trends Pharmacol Sci 1999; 20:329-37
44. Yang LC, Marsala M, Yaksh TL: Characterization of time course of spinal amino acids, citrulline and PGE2 release after carrageenan/kaolin-induced knee joint inflammation: A chronic microdialysis study. Pain 1996; 67:345-54
45. Scheuren N, Bang H, Munster T, Brune K, Pahl A: Modulation of transcription factor NF-κB by enantiomers of the nonsteroidal drug ibuprofen. Br J Pharmacol 1998; 123:645-52
46. Grilli M, Pizzi M, Memo M, Spano P: Neuroprotection by aspirin and sodium salicylate through blockage of NF-κB activation. Science 1996; 274: 1383-5
47. Mestre JR, Mackrell PJ, Rivadeneira DE, Stapleton PP, Tanabe T, Daly JM: Redundancy in the signaling pathways and promoter elements regulating cyclooxygenase-2 gene expression in endotoxin-treated macrophage/monocytic cells. J Biol Chem 2001; 276:3977-82
48. Nakao S, Ogata Y, Shimizu-Sasaki E, Yamazaki M, Furuyama S, Sugiya H: Activation of NFκB is necessary for IL-1β-induced cyclooxygenase-2 (COX-2) expression in human gingival fibroblasts. Mol Cell Biochem 2000; 209:113-8
49. Vanegas H, Schaible HG: Prostaglandins and cyclooxygenases in the spinal cord. Prog Neurobiol 2001; 64:327-63
50. Kawamata M, Omote K: Involvement of increased excitatory amino acids and intracellular Ca2+ concentration in the spinal dorsal horn in an animal model of neuropathic pain. Pain 1996; 68:85-96
51. Farooque M, Hillered L, Holtz A, Olsson Y: Changes of extracellular levels of amino acids after graded compression trauma to the spinal cord: An experimental study in the rat using microdialysis. J Neurotrauma 1996; 13:537-48
52. Kajander KC, Wakisaka S, Bennett GJ: Spontaneous discharge originates in the dorsal root ganglion at the onset of a painful peripheral neuropathy in the rat. Neurosci Lett 1992: 138:225-8
53. Yoon YW, Na HS, Chung JM: Contributions of injured and intact afferents to neuropathic pain in an experimental rat model. Pain 1996; 64:27-36
54. Vasko M, Campbell W, Waite K: Prostaglandin E2 enhances bradykinin stimulated release of neuropeptides from rat sensory neurons in culture. J Neurosci 1994; 14:4987-97
55. Wakisaka S, Kajander KC, Bennett GJ: Effects of peripheral nerve injuries and tissue inflammation on the levels of neuropeptide Y-like immunoreactivity in rat primary afferent neurons. Brain Res 1992; 598:349-52
56. LaMotte RH, Shain CN, Simone DA, Tsai EF: Neurogenic hyperalgesia: Psychophysical studies of underlying mechanisms. J Neurophysiol 1991; 66:190-211
57. Woolf CJ, Shortland P, Coggeshall RE: Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature 1992; 355:75-8
58. Herdegen T, Fiallos-Estrada CE, Schmid W, Bravo R, Zimmermann M: The transcription factors c-JUN, JUN D and CREB, but not FOS and KROX-24, are differentially regulated in axotomized neurons following transection of rat sciatic nerve. Mol Brain Res 1992; 14:155-65
59. Cameron-Curry P, Aste N, Viglietti-Panzica C, Panzica GC: Immunocytochemical distribution of glial fibrillary acidic protein in the central nervous system of the Japanese quail (Coturnix coturnix japonica). Anat Embryol Berl 1991; 184:571-81